Proxy WHO Disability Assessment Schedule 2.0 Is Clinically Useful for Assessing Psychosocial Functioning in Severe Mental Illness

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2020 May 1

PMID 32351419

Citations 6

Authors

Anne B Koopmans

Daphne van Hoeken

Diana E Clarke

David J Vinkers

Peter N van Harten

Hans W Hoek

Affiliations

Soon will be listed here.

Abstract

Aims: This study explores how well the World Health Organization Disability Assessment Schedule (WHODAS 2.0) assesses problems with psychosocial functioning in patients with severe mental illness (SMI). Further, we assessed the relationships between psychosocial functioning and psychopathology, medication side effects, treatment setting, and quality of life.

Methods: We performed an observational, cross-sectional study on the island of Curaçao to assess psychosocial functioning in 77 patients with SMI; they mainly had psychotic disorders. We interviewed their healthcare providers using the proxy version of the WHODAS 2.0. In addition, patients were examined for psychiatric symptoms, medication side effects (including drug-induced movement disorders), and quality of life. Associations were examined with Spearman's rank correlation (ρ).

Results: Difficulties in psychosocial functioning were reported by patients with SMI in the WHODAS 2.0 domains of understanding and communicating [mean (M)=34.5, standard deviation (SD)=18.6), participation in society (M=25.5, SD=15.6), and getting along with people (M=24.1, SD=16.1)]. Notably, outpatients had more problems participating in society than inpatients (M=33.6, SD=18.5 M=23.2, SD=14.1, p=0.03). A positive correlation was observed between drug-induced parkinsonism and the WHODAS 2.0 total score (ρ =0.30; p=0.02), as well as with various subscales, getting around, and household activities.

Conclusion: The proxy version of the WHODAS 2.0 is clinically useful for patients with severe mental illness. The highest scores on the WHODAS 2.0 were found in domains related to interactions with other people and to participation in society. Inpatient status appeared to aid participation in society; this might be due to living in the sheltered clinic environment and its associated daily activities. We further found that drug-induced parkinsonism was associated with a broad spectrum of psychosocial disabilities.

Clinical Trial Registration: ClinicalTrials.gov, identifier: NCT02713672; retrospectively registered in February 2016.

Citing Articles

Impact of Cognitive Disturbances and Clinical Symptoms on Disability in Patients with Paranoid Schizophrenia: A Study of a Bulgarian Clinical Sample.

Veleva I, Stoychev K, Stoimenova-Popova M, Mineva-Dimitrova E Int J Environ Res Public Health. 2023; 20(3).

PMID: 36767826 PMC: 9916146. DOI: 10.3390/ijerph20032459.

Peer-led recovery groups for people with psychosis in South Africa (PRIZE): protocol for a randomised controlled feasibility trial.

Asher L, Rapiya B, Repper J, Reddy T, Myers B, Hanlon C Pilot Feasibility Stud. 2023; 9(1):19.

PMID: 36726164 PMC: 9890934. DOI: 10.1186/s40814-022-01232-8.

Long-term disability in common mental disorders in Chinese community: evidence from a five-year follow-up study.

Zhang Y, Li M, Yin H, Ma C, Huang Z, Yan Y BMC Psychiatry. 2022; 22(1):727.

PMID: 36419029 PMC: 9682650. DOI: 10.1186/s12888-022-04382-4.

Item-level psychometrics of the Ascertain Dementia Eight-Item Informant Questionnaire.

Ham Y, Bae S, Lee H, Ha Y, Choi H, Park J PLoS One. 2022; 17(7):e0270204.

PMID: 35789335 PMC: 9255723. DOI: 10.1371/journal.pone.0270204.

Physical Healthcare, Health-Related Quality of Life and Global Functioning of Persons with a Severe Mental Illness in Belgian Long-Term Mental Health Assertive Outreach Teams: A Cross-Sectional Self-Reported Survey.

Martens N, Destoop M, Dom G Int J Environ Res Public Health. 2022; 19(9).

PMID: 35564916 PMC: 9100211. DOI: 10.3390/ijerph19095522.

References

Whitley R . Introducing recovery. Can J Psychiatry. 2014; 59(5):233-5. PMC: 4079136. DOI: 10.1177/070674371405900501. View

Shafer A . Meta-analysis of the brief psychiatric rating scale factor structure. Psychol Assess. 2005; 17(3):324-35. DOI: 10.1037/1040-3590.17.3.324. View

van Harten P, Matroos G, Hoek H, Kahn R . The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I. Schizophr Res. 1996; 19(2-3):195-203. DOI: 10.1016/0920-9964(95)00096-8. View

Gerlach J, Korsgaard S, Clemmesen P, Lauersen A, Magelund G, Noring U . The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand. 1993; 87(4):244-52. DOI: 10.1111/j.1600-0447.1993.tb03366.x. View

Green C, Perrin N, Leo M, Janoff S, Yarborough B, Paulson R . Recovery from serious mental illness: trajectories, characteristics, and the role of mental health care. Psychiatr Serv. 2013; 64(12):1203-10. PMC: 4330090. DOI: 10.1176/appi.ps.201200545. View

McInerney S, Finnerty S, Walsh E, Spelman L, Edgar N, Hallahan B . Quality of life and social functioning of former long-stay psychiatric patients transferred into the community: a 10 year follow up study. Soc Psychiatry Psychiatr Epidemiol. 2018; 53(8):795-801. DOI: 10.1007/s00127-018-1520-3. View

Lord S, Godfrey A, Galna B, Mhiripiri D, Burn D, Rochester L . Ambulatory activity in incident Parkinson's: more than meets the eye?. J Neurol. 2013; 260(12):2964-72. DOI: 10.1007/s00415-013-7037-5. View

Hofer A, Baumgartner S, Edlinger M, Hummer M, Kemmler G, Rettenbacher M . Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur Psychiatry. 2005; 20(5-6):386-94. DOI: 10.1016/j.eurpsy.2005.02.005. View

Sabbag S, Twamley E, Vella L, Heaton R, Patterson T, Harvey P . Assessing everyday functioning in schizophrenia: not all informants seem equally informative. Schizophr Res. 2011; 131(1-3):250-5. PMC: 3159808. DOI: 10.1016/j.schres.2011.05.003. View

10.

Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D . Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. Br J Psychiatry. 2014; 205(3):236-43. DOI: 10.1192/bjp.bp.112.122283. View

11.

Drake R, Whitley R . Recovery and severe mental illness: description and analysis. Can J Psychiatry. 2014; 59(5):236-42. PMC: 4079142. DOI: 10.1177/070674371405900502. View

12.

Thomas E, Despeaux K, Drapalski A, Bennett M . Person-Oriented Recovery of Individuals With Serious Mental Illnesses: A Review and Meta-Analysis of Longitudinal Findings. Psychiatr Serv. 2017; 69(3):259-267. DOI: 10.1176/appi.ps.201700058. View

13.

Apiquian R, Ulloa R, Herrera-Estrella M, Moreno-Gomez A, Erosa S, Contreras V . Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia. Schizophr Res. 2009; 112(1-3):181-6. DOI: 10.1016/j.schres.2009.03.028. View

14.

Goldman M, Spaeth-Rublee B, Pincus H . The Case for Severe Mental Illness as a Disparities Category. Psychiatr Serv. 2018; 69(6):726-728. PMC: 5984130. DOI: 10.1176/appi.ps.201700138. View

15.

Covell N, Weissman E, Schell B, McCorkle B, Summerfelt W, Weiden P . Distress with medication side effects among persons with severe mental illness. Adm Policy Ment Health. 2007; 34(5):435-42. DOI: 10.1007/s10488-007-0131-1. View

16.

Jaaskelainen E, Juola P, Hirvonen N, McGrath J, Saha S, Isohanni M . A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2012; 39(6):1296-306. PMC: 3796077. DOI: 10.1093/schbul/sbs130. View

17.

Siu C, Harvey P, Agid O, Waye M, Brambilla C, Choi W . Insight and subjective measures of quality of life in chronic schizophrenia. Schizophr Res Cogn. 2016; 2(3):127-132. PMC: 4788499. DOI: 10.1016/j.scog.2015.05.002. View

18.

Gold L . DSM-5 and the assessment of functioning: the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). J Am Acad Psychiatry Law. 2014; 42(2):173-81. View

19.

de Haan L, Weisfelt M, Dingemans P, Linszen D, Wouters L . Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale. Psychopharmacology (Berl). 2002; 162(1):24-8. DOI: 10.1007/s00213-002-1054-x. View

20.

Chopra P, Couper J, Herrman H . The assessment of patients with long-term psychotic disorders: application of the WHO Disability Assessment Schedule II. Aust N Z J Psychiatry. 2004; 38(9):753-9. DOI: 10.1080/j.1440-1614.2004.01448.x. View